Eve Williamson

Suggest Changes
Learn More
OBJECTIVE To estimate the willingness to pay for a new chemotherapy, raltitrexed (Tomudex trade mark ) over conventional therapy with fluorouracil plus leucovorin (FU-LV) from the perspective of(More)
  • 1